Download PDF
1 / Pages

Other users also viewed these articles

Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? Stefania Kiapidou; Christina Liava; Maria Kalogirou; Evangelos Akriviadis; Emmanouil Sinakos;
Ann Hepatol. 2020;19:134-44
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease Facundo Maiorana; Magali Neschuk; MarĂ­a Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;
10.1016/j.aohep.2024.101541